Related Experiment Video
Updated: Aug 30, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
[Screening: careful considerations versus commercial medicine]
1Medisch Centrum Rijnmond-Zuid, afd. Klinische Pathologie, Postbus 9119, 3007 AC Rotterdam. giardr@mcrz.nl
Abstract:
People no longer seem to view their state of health in a light-hearted manner. The worried well hunger for every scrap of information they can find about their physical well-being, with the result that a veritable diagnostic industry is developing. Is the early detection of a disease always better than waiting for its signs or symptoms? It is difficult to answer this question and properly weigh up the beneficial effects against the side effects. Two main reasons are given for this. First of all, studies on the early detection of disease report the results selectively: beneficial effects are overstated and side effects are underreported. A more comprehensive evaluation method is needed. Secondly, new technological and therapeutic innovations are in competition with the existing techniques under investigation, which makes a long-term evaluation almost impossible. Moreover, this approach obscures questions fundamental to screening practices. There is a widening gulf between medical screening and traditional medicine, with the result that care is being transformed into a commercial product with a huge market. These developments in diagnostics pose new scientific and ethical questions that need to be answered.
Related Concept Videos
Preventive Healthcare Services
Preclinical Development: Overview
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Drug Discovery: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Clinical Trials: Overview
